Fig. 2From: Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterationsKaplan Meier curves for the training (a, b) and validation (c, d) sets of ADC patients. For each case, patients were divided into two risk groups according to the predicted risk using either clinical (a, c) or clinical-genomic data (b, d). Survival curves were compared using log-rank test p-valuesBack to article page